In continuation to earlier announcements dated October 23, 2023, Orchid Pharma has informed that it enclosed copies of newspaper advertisements published in Financial Express (All India Edition - English) and Makkal Kural (Vernacular Language - Tamil) on October 28, 2023, regarding the Notice of the Postal Ballot of the Company including Cut-off date, Remote e-Voting information in accordance to Section 110 and 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 (as amended) and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Copy of the Newspaper Advertisement is also available on the website of the Company at www.orchidpharma.com
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1693.15 |
| Dr. Reddys Lab | 1221.25 |
| Cipla | 1230.75 |
| Zydus Lifesciences | 939.20 |
| Lupin | 2326.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: